The landscape of dementia prognosis has advanced dramatically with the advent of advanced biomarkers, such as amyloid PET scans, tau imaging, and blood-primarily based tests that may detect Alzheimer's pathology many years before signs and symptoms arise. When these technological improvements symbolize exceptional progress in understanding neurodegenerative health conditions, they https://garyv863scl2.wikiannouncement.com/user